BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 15963249)

  • 1. Matrix metalloproteinases and angiogenesis.
    Rundhaug JE
    J Cell Mol Med; 2005; 9(2):267-85. PubMed ID: 15963249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
    Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
    BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinases and their inhibitors in angiogenesis.
    Lafleur MA; Handsley MM; Edwards DR
    Expert Rev Mol Med; 2003 Sep; 5(23):1-39. PubMed ID: 14585170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.
    Arroyo AG; Genís L; Gonzalo P; Matías-Román S; Pollán A; Gálvez BG
    Curr Pharm Des; 2007; 13(17):1787-802. PubMed ID: 17584108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
    Bogaczewicz J; Dudek W; Zubilewicz T; Wroński J; Przywara S; Chodorowska G; Krasowska D
    Pol Merkur Lekarski; 2006 Jul; 21(121):80-5. PubMed ID: 17007300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinases and their inhibitors in tumor angiogenesis.
    Handsley MM; Edwards DR
    Int J Cancer; 2005 Jul; 115(6):849-60. PubMed ID: 15729716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase control of capillary morphogenesis.
    Ghajar CM; George SC; Putnam AJ
    Crit Rev Eukaryot Gene Expr; 2008; 18(3):251-78. PubMed ID: 18540825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
    van Hinsbergh VW; Koolwijk P
    Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases.
    Heissig B; Hattori K; Friedrich M; Rafii S; Werb Z
    Curr Opin Hematol; 2003 Mar; 10(2):136-41. PubMed ID: 12579040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activators and matrix metalloproteinases in angiogenesis.
    Mignatti P; Rifkin DB
    Enzyme Protein; 1996; 49(1-3):117-37. PubMed ID: 8797002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of matrix biology by matrix metalloproteinases.
    Mott JD; Werb Z
    Curr Opin Cell Biol; 2004 Oct; 16(5):558-64. PubMed ID: 15363807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].
    Naduk-Kik J; Hrabec E
    Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the matrix metalloproteinases during in vitro vessel formation.
    Burbridge MF; Cogé F; Galizzi JP; Boutin JA; West DC; Tucker GC
    Angiogenesis; 2002; 5(3):215-26. PubMed ID: 12831062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
    Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
    Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of matrix metalloproteinase inhibitors: angiogenesis and tumor models.
    Albert DH; Davidsen SK
    Curr Protoc Pharmacol; 2001 Aug; Chapter 5():Unit5.23. PubMed ID: 21959760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of extracellular matrix in retinal vascular development and preretinal neovascularization.
    Bishop PN
    Exp Eye Res; 2015 Apr; 133():30-6. PubMed ID: 25819452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.